Preventing atherosclerosis In a study that examined the effects exerted by liraglutide on the endothelium in mice models with early onset, low-burden atherosclerotic disease, liraglutide treatment in apolipoprotein E deficient (ApoE / ) mice inhibited the progression of early onset, low-burden atherosclerotic disease and enhanced plaque stability in a partially GLP-1R-dependent manner, without significantly affecting late onset, high-burden atherosclerotic disease
Ludwig MQ, Cheng W, Gordian D, Lee J, Paulsen SJ, Hansen SN, et al
These medications have become some of the most effective medications to improve blood sugar, reduce the risk of certain cardiovascular conditions, and lose weight out there, with people losing up to 15% to 21% of their bodyweight on average in a little more than a year
We refuse to be strong-armed by any pharmaceutical companys anticompetitive demands that infringe on the independent decision making of providers and limit patient choice," Dudum said in a statement to Fierce Healthcare
And remember, always follow your healthcare providers instructions when taking semaglutide or any other medication
Phase 3 clinical trials are still underway, coming to a close in May 2026